Status:

UNKNOWN

Efficacy of Topical Lidocaine/Prilocaine in Pain Management in Pleurocentesis

Lead Sponsor:

Assiut University

Conditions:

Pleural Effusion

Eligibility:

All Genders

18-80 years

Phase:

PHASE4

Brief Summary

The research aims to compare the efficacy of topical Pridocaine cream (lidocaine 2.5% and prilocaine 2.5%) and the standardized local lidocaine infiltration in pain management before pleurocentesis.

Detailed Description

Acute pain management is a core ethical concept in medical practice. During pleurocentesis, the standardized pain management is with 1% lidocaine with a 25 gauge needle for skin and a smaller gauge ne...

Eligibility Criteria

Inclusion

  • All Patients will be prepared for pleurocentesis.

Exclusion

  • Patients with a known history of sensitivity to local anesthetics of the amide type or to any other component of the product.
  • Patients treated with class III anti-arrhythmic drugs (e.g., amiodarone, bretylium, sotalol, dofetilide).

Key Trial Info

Start Date :

January 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2023

Estimated Enrollment :

118 Patients enrolled

Trial Details

Trial ID

NCT05984264

Start Date

January 1 2023

End Date

December 1 2023

Last Update

August 9 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Assuit University Hospital

Asyut, Egypt, Assiut university 71515

Efficacy of Topical Lidocaine/Prilocaine in Pain Management in Pleurocentesis | DecenTrialz